Brief Article5-Azacytidine as Salvage Treatment in Relapsed Myeloid Tumors after Allogeneic Bone Marrow Transplantation
Under a Creative Commons license
open archive
Key Words
Acute myeloid leukemia
Donor lymphocyte infusion
5-Azacytidine
Myelodysplastic syndrome
Graft-versus-host disease
Cited by (0)
Financial disclosure: See Acknowledgments on page 757.
Copyright © 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.